File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials

TitleCOVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials
Authors
Yan, ZPYang, MLai, CL
KeywordsCOVID-19
Vaccine
Safety
Efficacy
Herd immunity
Issue Date2021
PublisherMolecular Diversity Preservation International. The Journal's web site is located at http://www.mdpi.org/pharmaceuticals/index.htm
Citation
Pharmaceuticals, 2021, v. 14 n. 5, article no. 406 How to Cite?
DOI: http://dx.doi.org/10.3390/ph14050406
AbstractVarious strategies have been designed to contain the COVID-19 pandemic. Among them, vaccine development is high on the agenda in spite of the unknown duration of the protection time. Various vaccines have been under clinical trials with promising results in different countries. The protective efficacy and the short-term and long-term side effects of the vaccines are of major concern. Therefore, comparing the protective efficacy and risks of vaccination is essential for the global control of COVID-19 through herd immunity. This study reviews the most recent data of 12 vaccines to evaluate their efficacy, safety profile and usage in various populations.
Persistent Identifierhttp://hdl.handle.net/10722/304545
ISSN
1424-8247
2023 Impact Factor: 4.3
2023 SCImago Journal Rankings: 0.845
PubMed Central ID
PMC8144958
ISI Accession Number ID
WOS:000654391800001

 

DC FieldValueLanguage
dc.contributor.authorYan, ZP-
dc.contributor.authorYang, M-
dc.contributor.authorLai, CL-
dc.date.accessioned2021-09-23T09:01:34Z-
dc.date.available2021-09-23T09:01:34Z-
dc.date.issued2021-
dc.identifier.citationPharmaceuticals, 2021, v. 14 n. 5, article no. 406-
dc.identifier.issn1424-8247-
dc.identifier.urihttp://hdl.handle.net/10722/304545-
dc.description.abstractVarious strategies have been designed to contain the COVID-19 pandemic. Among them, vaccine development is high on the agenda in spite of the unknown duration of the protection time. Various vaccines have been under clinical trials with promising results in different countries. The protective efficacy and the short-term and long-term side effects of the vaccines are of major concern. Therefore, comparing the protective efficacy and risks of vaccination is essential for the global control of COVID-19 through herd immunity. This study reviews the most recent data of 12 vaccines to evaluate their efficacy, safety profile and usage in various populations.-
dc.languageeng-
dc.publisherMolecular Diversity Preservation International. The Journal's web site is located at http://www.mdpi.org/pharmaceuticals/index.htm-
dc.relation.ispartofPharmaceuticals-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCOVID-19-
dc.subjectVaccine-
dc.subjectSafety-
dc.subjectEfficacy-
dc.subjectHerd immunity-
dc.titleCOVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials-
dc.typeArticle-
dc.identifier.emailLai, CL: hrmelcl@hkucc.hku.hk-
dc.identifier.authorityLai, CL=rp00314-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.3390/ph14050406-
dc.identifier.pmid33923054-
dc.identifier.pmcidPMC8144958-
dc.identifier.scopuseid_2-s2.0-85105538636-
dc.identifier.hkuros325484-
dc.identifier.volume14-
dc.identifier.issue5-
dc.identifier.spagearticle no. 406-
dc.identifier.epagearticle no. 406-
dc.identifier.isiWOS:000654391800001-
dc.publisher.placeSwitzerland-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats